At Reon Biotech, we pioneer advanced solutions to combat antimicrobial resistance through
cutting-edge research, innovative formulations, and patient-centric approaches.
Reon Biotech is a pioneering pharmaceutical company based in India, dedicated to advancing healthcare through innovative products and groundbreaking solutions.
We specialize in Alternative Dosing and unique dosage Formulations in the field of Antibiotics and Antifungals. Our mission is to combat the growing challenges posed by bacterial resistance mechanisms with our cutting-edge BLI (Beta-lactamase Inhibitors) products and unique dosage formulations.
Committed to improving patient outcomes through pharmaceutical innovation
At Reon Biotech, we are driven by a passion for excellence in pharmaceutical research and development. We understand the pressing need for new and effective solutions to combat antibiotic resistance, and we are committed to delivering products that can make a difference in patients' lives.
Continuously pushing boundaries in pharmaceutical research to develop groundbreaking solutions that address healthcare challenges.
Working together with healthcare professionals, researchers, and partners to achieve common goals in improving patient care.
Putting patients at the center of everything we do, ensuring our solutions improve quality of life and treatment outcomes.
Research Projects
Product Formulations
Expert Team Members
Industry Awards
This is how we're going to make it big in the pharmaceutical industry through innovation and collaboration.
Collaboration and teamwork are the foundation of our innovative process. We believe in the power of collective expertise.
Rigorous analysis and open dialogue drive our decision-making process for optimal outcomes.
Developing cutting-edge solutions to address healthcare challenges with innovative approaches.
Building lasting relationships through value-driven solutions and exceptional service.
Our commitment to innovation extends across all aspects of pharmaceutical development. We leverage cutting-edge technologies and scientific expertise to create solutions that address the most pressing healthcare challenges.
Advanced research methodologies
State-of-the-art formulation techniques
Rigorous quality control processes
Sustainable manufacturing practices
Patient-centric design approach
Continuous improvement culture
Driving pharmaceutical innovation through dedicated research and development
We believe in thinking outside the box when it comes to dosing strategies. Our alternative dosing solutions are designed to optimize treatment outcomes while minimizing side effects and resistance development.
We are constantly exploring new dosing regimens to stay one step ahead of evolving pathogens.
Our team of experts works tirelessly to develop unique dosage formulations that enhance the effectiveness and patient compliance of antibiotic and antifungal treatments.
We recognize that patient comfort and adherence are crucial for successful therapy.
Beta-lactamase inhibitors (BLIs) are at the forefront of the battle against bacterial resistance. We have developed a range of BLI products that not only counteract resistance mechanisms but also enhance the efficacy of antibiotics.
Our innovative BLIs are a vital tool in the fight against antibiotic-resistant infections.
We specialize in Alternative Dosing and unique dosage Formulations in the field of Antibiotics and Antifungals. Our mission is to combat the growing challenges posed by bacterial resistance mechanisms with our cutting-edge BLI products and unique dosage formulations.
Committed to better health outcomes through innovative solutions
Building lasting relationships based on mutual trust and common goals
Focusing on patient-centric results and improved treatment efficacy
Driving innovation and positive change in healthcare delivery
Pioneering pharmaceutical research with cutting-edge technologies
Adhering to highest quality standards and regulatory compliance
We believe in thinking outside the box when it comes to dosing strategies. Our alternative dosing solutions are designed to optimize treatment outcomes while minimizing side effects and resistance development.
Tailored dosing strategies that maximize efficacy while reducing adverse effects and preventing resistance development.
Advanced pharmacokinetic/pharmacodynamic modeling to establish optimal dosing schedules for various patient populations.
Customized dosing protocols based on individual patient characteristics, comorbidities, and treatment responses.
Rigorous clinical trials and real-world evidence studies to validate the safety and efficacy of alternative dosing regimens.
Our team of experts works tirelessly to develop unique dosage formulations that enhance the effectiveness and patient compliance of antibiotic and antifungal treatments.
Formulations designed for sustained drug release, reducing dosing frequency and improving patient adherence.
Pediatric and geriatric-friendly formulations with improved palatability and ease of administration.
Stable and ready-to-use injectable formulations for hospital and clinical settings.
Fixed-dose combinations that simplify treatment regimens and enhance therapeutic outcomes.
Our innovative Beta-lactamase Inhibitors are at the forefront of the battle against bacterial resistance, designed to counteract resistance mechanisms and enhance antibiotic efficacy.
Effective against a wide range of beta-lactamase enzymes, including ESBLs and carbapenemases.
Optimized combinations with beta-lactam antibiotics for enhanced antimicrobial activity.
Ready-to-use formulations specifically designed for critical care and hospital settings.
Enhanced stability profiles for improved shelf-life and storage conditions.
Comprehensive R&D services from discovery through development, leveraging cutting-edge technologies and scientific expertise.
High-throughput screening and rational drug design for novel antimicrobial agents.
Comprehensive in vitro and in vivo studies to establish safety and efficacy profiles.
Development of stable, bioavailable, and patient-friendly dosage forms.
Complete regulatory strategy and documentation support for global submissions.
Collaborative opportunities for pharmaceutical companies, research institutions, and healthcare organizations.
GMP-compliant manufacturing facilities for scale-up and commercial production.
Partnerships with research institutions for innovative discovery projects.
Licensing opportunities for our innovative formulations in global markets.
Strategic joint ventures for co-development and commercialization of products.
We provide end-to-end pharmaceutical services, from research and development to manufacturing and commercialization.
Innovative dosing strategies optimized for efficacy, safety, and resistance prevention through advanced PK/PD modeling.
Contact UsDevelopment of unique dosage forms including extended-release, pediatric-friendly, and combination formulations.
Contact UsCutting-edge Beta-lactamase Inhibitors designed to combat antibiotic resistance and enhance therapeutic outcomes.
Contact UsComprehensive in vitro and in vivo studies to establish safety, efficacy, and pharmacokinetic profiles.
Contact UsGMP-compliant manufacturing with scale-up capabilities for clinical and commercial production.
Contact UsExpert guidance on regulatory submissions, compliance, and approvals for global markets.
Contact UsA systematic approach to pharmaceutical innovation that ensures quality, efficacy, and patient safety at every stage.
Identify novel targets and develop innovative approaches to combat antimicrobial resistance.
Formulation optimization, preclinical studies, and analytical method development.
Clinical trials, stability studies, and manufacturing process validation.
Regulatory submissions, scale-up manufacturing, and market launch support.
Partner with Reon Biotech for innovative pharmaceutical solutions that address the growing challenge of antimicrobial resistance.
